Method for Treating Phytophotodermatitis
US-2016030379-A1 · Feb 4, 2016 · US
US10308599B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10308599-B2 |
| Application number | US-201615370658-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 6, 2016 |
| Priority date | Jan 3, 2011 |
| Publication date | Jun 4, 2019 |
| Grant date | Jun 4, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An isothiocyanate functional surfactant, wherein the protonated form of the surfactant includes the structure of formula (IA): wherein R 1 includes the structure of formula (IIA), (IIIA), or (IVA), wherein X includes an integer ranging from approximately 0 to approximately 20, wherein R 2 comprises a linear or branched aliphatic group containing approximately 8 to approximately 25 carbon atoms, and wherein R 3 comprises an aliphatic or aromatic group containing approximately 1 to approximately 20 carbon atoms and at least one—N═C═S group.
Opening claim text (preview).
What is claimed and desired to be secured by Letters Patent of the United States is: 1. A compound represented by the structure of formula (IA): wherein R 1 is selected from the group consisting of the structures of formula (IIA), (IIIA), and (IVA); wherein X is an integer ranging from 1 to 20; wherein R 2 is a linear or branched aliphatic group containing 8 to 25 carbon atoms; and wherein R 3 is an aliphatic or aromatic group containing 1 to 20 carbon atoms and at least one—N═C═S group. 2. The compound according to claim 1 , wherein R 1 is the structure of formula (IIA). 3. The compound according to claim 2 , wherein R 2 is an aliphatic group containing 12 to 20 carbon atoms. 4. The compound according to claim 1 , wherein R 1 is the structure of formula (IIIA). 5. The compound according to claim 4 , wherein R 2 is an aliphatic group containing 12 to 20 carbon atoms. 6. The compound according to claim 1 , wherein R 1 is the structure of formula (IVA). 7. The compound according to claim 6 , wherein R 2 is an aliphatic group containing 12 to 20 carbon atoms. 8. A compound represented by structure of formula (IB): wherein R 1 is selected from the group consisting of the structures of formula (IIB), (IIIB), and (IVB); wherein X is an integer ranging from 0 to 20; wherein R 2 is a linear or branched aliphatic group containing 8 to 25 carbon atoms; wherein R 3 is an aliphatic or aromatic group containing 1 to 20 carbon atoms and at least one—N═C═S group; and wherein M + is selected from the group consisting of Li + , Na + , K + , and H + . 9. The compound according to claim 8 , wherein R 1 is the structure of formula (IIB). 10. The compound according to claim 9 , wherein R 2 is an aliphatic group containing 12 to 20 carbon atoms. 11. The compound according to claim 8 , wherein R 1 is the structure of formula (IIIB). 12. The compound according to claim 11 , wherein R 2 is an aliphatic group containing 12 to 20 carbon atoms. 13. The compound according to claim 8 , wherein R 1 is the structure of formula (IVB). 14. The compound according to claim 13 , wherein R 2 is an aliphatic group containing 12 to 20 carbon atoms. 15. A formulation, comprising: a compound represented by the structure of formula (IB): wherein R 1 is selected from the group consisting of the structures of formula (IIB), (IIIB), and (IVB); wherein X is an integer ranging from 1 to 20; wherein R 2 is a linear or branched aliphatic group containing 8 to 25 carbon atoms; wherein R 3 is an aliphatic or aromatic group containing 1 to 20 carbon atoms and at least one—N═C═S group; wherein M + is selected from the group consisting of Li + , Na + , K + , and H + ; and a non-hygroscopic solvent. 16. The formulation according to claim 15 , wherein R 1 is the structure of formula (IIB). 17. The formulation according to claim 16 , wherein R 2 is an aliphatic group containing 12 to 20 carbon atoms. 18. The formulation according to claim 15 , wherein R 1 is the structure of formula (IIIB). 19. The formulation according to claim 18 , wherein R 2 is an aliphatic group containing 12 to 20 carbon atoms. 20. The formulation according to claim 15 , wherein R 1 is the structure of formula (IVB). 21. The formulation according to claim 20 , wherein R 2 is an aliphatic group containing 12 to 20 carbon atoms.
Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00) · CPC title
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters · CPC title
Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title
of a saturated carbon skeleton · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.